Refine by
Gastroesophageal Equipment Supplied In Europe
8 equipment items found
by:LANOVA Farmaceutici based inROMA, ITALY
Dosage/Packaging: 14 / 28 tablet, 20 mg, 14 / 28 tablet, 40 mg. Shelf life: 48 months. Indication: Symptomatic gastroesophageal reflux disease. For the long-term treatment and prevention of relapse of reflux ...
Manufactured by:Cook Medical LLC based inBloomington, INDIANA (USA)
Used to endoscopically ligate esophageal varices at or above the gastroesophageal junction or to ligate internal hemorrhoids. ...
Manufactured by:Cook Medical LLC based inBloomington, INDIANA (USA)
Used to endoscopically ligate esophageal varices at or above the gastroesophageal junction or to ligate internal hemorrhoids. ...
Manufactured by:Marflow AG based inAdliswil, SWITZERLAND
Used for endoscopic ligation of esophageal, varices at or above gastroesophageal junction, Fits on wide range of endoscopes, Second last band light colour, Barrel with 7 bands available, Standard Band Ligator, Requires 9.5 to 11.2 mm, Endoscope diameter, Paediatric Band Ligator, Requires 8.0 to 9.5 mm, Endoscope ...
Manufactured by:CEATEC Medizintechnik GmbH based inWurmlingen, GERMANY
The Nathanson retractor have proven to be ideal for primarily in Gastroesophageal Reflux Disease procedures, but can also be used in a wide range of laparoscopic surgeries as they support the entire liver to provide atraumatic exposure. The Holding and Positioning Arm can be also used for open surgery, enabling a better view of the operating ...
Manufactured by:Perrery Farmaceutici S.r.l. based inPescantina (VR), ITALY
ESOMER is a drug, which due to a specific mechanism of action reduces the intensity of acid secretion in the ...
Manufactured by:Precirix based inBrussels, BELGIUM
Our lead product candidate, CAM-H2, consists of an HER2-targeting single-domain antibody linked to iodine-131. This targeted radioligand therapy is being developed for the treatment of patients with metastatic HER2-positive cancer indications, such as breast and gastric adenocarcinoma. In addition to the company’s lead program, two product candidates for undisclosed oncology targets are ...
Manufactured by:HTL Biotechnology based inJavene, FRANCE
HTL is offering a new source of Chondroitin Sulfate and other derivatives, of non-animal origin. While most Chondroitin Sulfate on the market is of animal origin (bovine, pig, shark, fish, bird), HTL is developing a new source of Chondroitin Sulfate of non-animal origin, using ...